by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Cannabis Marijuana
Cannabidiol, better known as CBD, is rapidly gaining popularity as a potion to treat almost every kind of medical concern you can think of, but scientific evidence is scant outside of a few clinically proven indications. A new study from a team of Canadian researchers...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Cannabis Marijuana
A broad drug reform bill has been introduced to the California state legislature proposing to decriminalize the possession and personal use of a number of psychedelic drugs, including LSD, psilocybin and MDMA. The bill proposes to expunge all criminal convictions...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Alcoholism
A new study published in the Journal of Psychopharmacology is reporting on a landmark clinical trial exploring the potential for MDMA-assisted psychotherapy in treating subjects with alcohol use disorder. The small open-label trial is the first to test MDMA therapy as...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Anxiety, Depression, Microdosing
A first of its kind “self-blinded” trial testing the effect of psychedelic microdosing has found the anecdotally popular practice may be an example of a strong placebo effect. The research, led by Imperial College London, suggests there is little...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Anxiety, Depression
A first-of-its-kind clinical trial has pitted a common antidepressant against psilocybin, the main psychedelic compound found in magic mushrooms. The results, recently published in the New England Journal of Medicine, are decidedly mixed with the primary depression...
